Chang-Han Lee
Overview
Explore the profile of Chang-Han Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
700
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kim J, Jeong J, Lee C, Lee D, Kang C, Choe P, et al.
Front Immunol
. 2022 Dec;
13:1028102.
PMID: 36466861
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants brought waves of pandemics with breakthrough infections in vaccinated individuals. We analyzed the antibody responses after primary and booster...
12.
Kwon Y, Seo E, Jeong A, Lee S, Noh K, Lee S, et al.
BMC Cancer
. 2022 Aug;
22(1):852.
PMID: 35927628
Tumor acidosis, a common phenomenon in solid cancers such as breast cancer, is caused by the abnormal metabolism of cancer cells. The low pH affects cells surrounding the cancer, and...
13.
Kang C, Kim M, Hong J, Kim G, Lee S, Chang E, et al.
Front Immunol
. 2022 Jun;
13:929770.
PMID: 35686133
[This corrects the article DOI: 10.3389/fimmu.2022.830433.].
14.
Kang C, Shin H, Choe P, Park J, Hong J, Seo J, et al.
BMC Med
. 2022 May;
20(1):181.
PMID: 35508998
Background: Practical guidance is needed regarding the vaccination of coronavirus disease 2019 (COVID-19) convalescent individuals in resource-limited countries. It includes the number of vaccine doses that should be given to...
15.
Kang C, Kim M, Hong J, Kim G, Lee S, Chang E, et al.
Front Immunol
. 2022 Apr;
13:830433.
PMID: 35392102
Background: Despite the fact of ongoing worldwide vaccination programs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), understanding longevity, breadth, and type of immune response to coronavirus disease-19 (COVID-19) is...
16.
Kang C, Kim M, Lee S, Kim G, Choe P, Beom Park W, et al.
J Infect Dis
. 2022 Mar;
227(9):1113-1114.
PMID: 35258550
No abstract available.
17.
Jeong H, Lee D, Kim S, Lee C, Shin H, Kim H, et al.
Oncogene
. 2022 Jan;
41(11):1634-1646.
PMID: 35094008
Diabetes mellitus (DM) characterized by hyperglycemia is a chronic metabolic disorder that leads to many symptoms and vascular complications. Despite the close association between DM and cancer progression, the response...
18.
Park J, Lee C
Trends Pharmacol Sci
. 2021 Dec;
43(5):352-354.
PMID: 34895946
Although endothelin receptor type A (ET) is emerging as a novel anticancer target, previously only small molecule drugs have been available as ET antagonists. Ju and colleagues have successfully developed...
19.
Lee C, Delidakis G
Methods Mol Biol
. 2021 Dec;
2421:187-200.
PMID: 34870820
Fc-mediated effector functions are important for the clearance of pathologic cells by therapeutic IgG antibodies through two mechanisms: via the activation of the classical complement pathway and through the binding...
20.
Kang S, Lee C
Biotechnol Bioprocess Eng
. 2021 Jul;
26(3):295-311.
PMID: 34220207
Monoclonal antibodies (mAb) have been used as therapeutic agents for various diseases, and immunoglobulin G (IgG) is mainly used among antibody isotypes due to its structural and functional properties. So...